Nonadherence to immune-modifying therapies during the COVID-19 pandemic: the crucial role of doctor-patient communication in avoiding drug discontinuation.

Journal Article Nonadherence to immune-modifying therapies during the COVID-19 pandemic: the crucial role of doctor–patient communication in avoiding drug discontinuation Get access Mario Valenti, Mario Valenti Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, ItalyDermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy Search for other works by this author on: Oxford Academic Google Scholar Antonio Costanzo Antonio Costanzo Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, ItalyDermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy Correspondence: Antonio Costanzo. Email: antonio.costanzo@hunimed.eu Search for other works by this author on: Oxford Academic Google Scholar British Journal of Dermatology, Volume 188, Issue 5, May 2023, Pages 586–590, https://doi.org/10.1093/bjd/ljad014 Published: 19 January 2023 Article history Received: 13 January 2023 Published: 19 January 2023 Corrected and typeset: 14 February 2023 Accepted: 23 February 2023